Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

Yoko S. Derose, Guoying Wang, Yi Chun Lin, Philip S. Bernard, Saundra S. Buys, Mark T W Ebbert, Rachel Factor, Cindy Matsen, Brett A. Milash, Edward Nelson, Leigh A Neumayer, R. Lor Randall, Inge J. Stijleman, Bryan E. Welm, Alana L. Welm

Research output: Contribution to journalArticle

472 Citations (Scopus)

Abstract

Development and preclinical testing of new cancer therapies is limited by the scarcity of in vivo models that authentically reproduce tumor growth and metastatic progression. We report new models for breast tumor growth and metastasis in the form of transplantable tumors derived directly from individuals undergoing treatment for breast cancer. These tumor grafts illustrate the diversity of human breast cancer and maintain essential features of the original tumors, including metastasis to specific sites. Co-engraftment of primary human mesenchymal stem cells maintains phenotypic stability of the grafts and increases tumor growth by promoting angiogenesis. We also report that tumor engraftment is a prognostic indicator of disease outcome for women with newly diagnosed breast cancer; orthotopic breast tumor grafting is a step toward individualized models for tumor growth, metastasis and prognosis. This bank of tumor grafts also serves as a publicly available resource for new models in which to study the biology of breast cancer.

Original languageEnglish (US)
Pages (from-to)1514-1520
Number of pages7
JournalNature Medicine
Volume17
Issue number11
DOIs
StatePublished - Nov 2011
Externally publishedYes

Fingerprint

Pathology
Grafts
Tumors
Breast Neoplasms
Neoplasm Metastasis
Transplants
Growth
Neoplasms
Mesenchymal Stromal Cells
Stem cells
Therapeutics
Testing

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Derose, Y. S., Wang, G., Lin, Y. C., Bernard, P. S., Buys, S. S., Ebbert, M. T. W., ... Welm, A. L. (2011). Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nature Medicine, 17(11), 1514-1520. https://doi.org/10.1038/nm.2454

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. / Derose, Yoko S.; Wang, Guoying; Lin, Yi Chun; Bernard, Philip S.; Buys, Saundra S.; Ebbert, Mark T W; Factor, Rachel; Matsen, Cindy; Milash, Brett A.; Nelson, Edward; Neumayer, Leigh A; Randall, R. Lor; Stijleman, Inge J.; Welm, Bryan E.; Welm, Alana L.

In: Nature Medicine, Vol. 17, No. 11, 11.2011, p. 1514-1520.

Research output: Contribution to journalArticle

Derose, YS, Wang, G, Lin, YC, Bernard, PS, Buys, SS, Ebbert, MTW, Factor, R, Matsen, C, Milash, BA, Nelson, E, Neumayer, LA, Randall, RL, Stijleman, IJ, Welm, BE & Welm, AL 2011, 'Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes', Nature Medicine, vol. 17, no. 11, pp. 1514-1520. https://doi.org/10.1038/nm.2454
Derose, Yoko S. ; Wang, Guoying ; Lin, Yi Chun ; Bernard, Philip S. ; Buys, Saundra S. ; Ebbert, Mark T W ; Factor, Rachel ; Matsen, Cindy ; Milash, Brett A. ; Nelson, Edward ; Neumayer, Leigh A ; Randall, R. Lor ; Stijleman, Inge J. ; Welm, Bryan E. ; Welm, Alana L. / Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. In: Nature Medicine. 2011 ; Vol. 17, No. 11. pp. 1514-1520.
@article{a319fe70a53c44a09d7ce0ba08dd3569,
title = "Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes",
abstract = "Development and preclinical testing of new cancer therapies is limited by the scarcity of in vivo models that authentically reproduce tumor growth and metastatic progression. We report new models for breast tumor growth and metastasis in the form of transplantable tumors derived directly from individuals undergoing treatment for breast cancer. These tumor grafts illustrate the diversity of human breast cancer and maintain essential features of the original tumors, including metastasis to specific sites. Co-engraftment of primary human mesenchymal stem cells maintains phenotypic stability of the grafts and increases tumor growth by promoting angiogenesis. We also report that tumor engraftment is a prognostic indicator of disease outcome for women with newly diagnosed breast cancer; orthotopic breast tumor grafting is a step toward individualized models for tumor growth, metastasis and prognosis. This bank of tumor grafts also serves as a publicly available resource for new models in which to study the biology of breast cancer.",
author = "Derose, {Yoko S.} and Guoying Wang and Lin, {Yi Chun} and Bernard, {Philip S.} and Buys, {Saundra S.} and Ebbert, {Mark T W} and Rachel Factor and Cindy Matsen and Milash, {Brett A.} and Edward Nelson and Neumayer, {Leigh A} and Randall, {R. Lor} and Stijleman, {Inge J.} and Welm, {Bryan E.} and Welm, {Alana L.}",
year = "2011",
month = "11",
doi = "10.1038/nm.2454",
language = "English (US)",
volume = "17",
pages = "1514--1520",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

AU - Derose, Yoko S.

AU - Wang, Guoying

AU - Lin, Yi Chun

AU - Bernard, Philip S.

AU - Buys, Saundra S.

AU - Ebbert, Mark T W

AU - Factor, Rachel

AU - Matsen, Cindy

AU - Milash, Brett A.

AU - Nelson, Edward

AU - Neumayer, Leigh A

AU - Randall, R. Lor

AU - Stijleman, Inge J.

AU - Welm, Bryan E.

AU - Welm, Alana L.

PY - 2011/11

Y1 - 2011/11

N2 - Development and preclinical testing of new cancer therapies is limited by the scarcity of in vivo models that authentically reproduce tumor growth and metastatic progression. We report new models for breast tumor growth and metastasis in the form of transplantable tumors derived directly from individuals undergoing treatment for breast cancer. These tumor grafts illustrate the diversity of human breast cancer and maintain essential features of the original tumors, including metastasis to specific sites. Co-engraftment of primary human mesenchymal stem cells maintains phenotypic stability of the grafts and increases tumor growth by promoting angiogenesis. We also report that tumor engraftment is a prognostic indicator of disease outcome for women with newly diagnosed breast cancer; orthotopic breast tumor grafting is a step toward individualized models for tumor growth, metastasis and prognosis. This bank of tumor grafts also serves as a publicly available resource for new models in which to study the biology of breast cancer.

AB - Development and preclinical testing of new cancer therapies is limited by the scarcity of in vivo models that authentically reproduce tumor growth and metastatic progression. We report new models for breast tumor growth and metastasis in the form of transplantable tumors derived directly from individuals undergoing treatment for breast cancer. These tumor grafts illustrate the diversity of human breast cancer and maintain essential features of the original tumors, including metastasis to specific sites. Co-engraftment of primary human mesenchymal stem cells maintains phenotypic stability of the grafts and increases tumor growth by promoting angiogenesis. We also report that tumor engraftment is a prognostic indicator of disease outcome for women with newly diagnosed breast cancer; orthotopic breast tumor grafting is a step toward individualized models for tumor growth, metastasis and prognosis. This bank of tumor grafts also serves as a publicly available resource for new models in which to study the biology of breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=81255135837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81255135837&partnerID=8YFLogxK

U2 - 10.1038/nm.2454

DO - 10.1038/nm.2454

M3 - Article

C2 - 22019887

AN - SCOPUS:81255135837

VL - 17

SP - 1514

EP - 1520

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 11

ER -